Viewing Study NCT06413940



Ignite Creation Date: 2024-05-19 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06413940
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-14
First Post: 2024-04-26

Brief Title: Exploring the Clinical Efficacy of Remote Management Applications Through Comprehensive Physical Therapy for Patients With Moderate to Severe Sleep Apnea
Sponsor: China National Center for Cardiovascular Diseases
Organization: China National Center for Cardiovascular Diseases

Study Overview

Official Title: Effect of Mobile-health and Comprehensive Physical Therapy on Moderate-to-severe Obstructive Sleep Apnea Hypoventilation Syndrome
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To observe comprehensive physical therapy program for OSAHS patients
Detailed Description: This study proposes to conduct a randomized controlled trial using an APP and wearable devices to provide comprehensive physical therapy and monitoring for people with moderate to severe OSAHSto assess the effectiveness and adherence of different physiotherapy programs for patients with moderate-to-severe OSAHS by observing the improvement of sleep apnea hypoventilation index AHI nocturnal minimum oxygen saturation Low SpO2 mean oxygen saturation Mean SpO2 and other health outcomes in the study population It is expected to explore a clinical treatment pathway suitable for patients with moderate-to-severe OSAHS through mobile app and comprehensive physical therapy improve the treatment adherence of OSAHS patients enhance the level of health management services in hospitals and obtain more physical health and health economic benefits

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None